You are here

P&T News

January 30

Both are pharmaco-enhanced protease inhibitors
Significance of genetic changes remains unclear
Treatment prolongs progression-free survival
Authors propose ways to cut ED waiting times

January 29

Scientists find novel way to kill resistant bacteria
Caps are ‘very small idea,’ experts says

January 28

Commonly used drugs eradicate cancer stem cells
First percutaneous single-access pump for right heart support

January 27

Half of annual payments would go to health care providers by end of 2018
Expensive treatments could test insurers’ ability to pay for them, report says
Iron compound delivered to hemodialysis patients via dialysate

January 26

Data-sharing capability allows caregivers to monitor patient’s blood sugar levels remotely
Vaccine granted ‘breakthrough therapy’ status

January 23

Paper-clip-sized implant inserted in upper thigh
Opioid exposure during pregnancy increases risk of birth defects
Mid-stage data show superiority over doxorubicin
Younger population more likely to be diagnosed with advanced disease, authors say

January 22

Scripps researchers recognize importance of molecular ‘handed-ness’
XRCC2 mutation may explain resistance to platinum-based therapy
Patient wears small, external insulin pump
First IL-17A antagonist for moderate-to-severe plaque psoriasis

January 21

Case could block doctors and hospitals from seeking higher rates
Reduced competition is part of the problem, expert says
Vaccine protects against 70% of cervical cancers

January 20

Experts review the good, the bad, and the doubtful
Drugs have to keep up with ‘genomic drift’
Novel approach may lead to next generation of better, safer anesthetic agents
Risk of relapse reduced by half compared with placebo
Common disease kills more people each day than Ebola, expert says

January 19

NIH study finds most older people use alcohol-interactive medications
Mid-stage data support treatment’s immunostimulatory mechanism of action
Polymer nanoparticles release targeted drug molecules
Global cost could reach $70 trillion over next decade
New formulation improves on once-monthly Invega Sustenna